PDF) Disease-specific outcomes of Radical Prostatectomies in Northern Norway; A case for the impact of perineural infiltration and postoperative PSA-doubling time
Introduction Evidence Based Radiation Oncology Fact Sheets Prostate Cancer 2022
Rates of change in PSA (ng/ml/yr) and PSA doubling time (yr) for... | Download Table
PSA Doubling Time Calculator
PDF) Disease-specific outcomes of Radical Prostatectomies in Northern Norway; A case for the impact of perineural infiltration and postoperative PSA-doubling time
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
Proposal for a Standardized PSA Doubling-time Calculation | Anticancer Research
PSA Doubling Time Calculator
Calculadoras – Urología Basada en Evidencia
Prostate Cancer Calculators
PSA Doubling Time Calculator
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy - ScienceDirect
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer | Prostate Cancer and Prostatic Diseases
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Practical rules for calculating PSA doubling time
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis | Nature Medicine
PSA Doubling Time Calculator
PSA Doubling Time Calculator
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
Rates of change in PSA (ng/ml/yr) and PSA doubling time (yr) for... | Download Table
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer | Prostate Cancer and Prostatic Diseases
